[Articles] Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system

May, 05, 2024 | Select Oncology Journal Articles

Alternative pembrolizumab administration strategies might have environmental advantages over the current dosing and compounding paradigms. Specialty medication dosing can be optimised for health-care spending and environmental sustainability without sacrificing clinical outcomes.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy